Prevention of pacemaker infections with perioperative antimicrobial treatment: An in vitro study

Europace

Volumn 16, Issue 4, 2014, Pages 604-611

  Marsch, Georg ^a   Mashaqi, Bakr ^a   Burgwitz, Karin ^a   Bisdas, Theodosios ^a   Knigina, Ludmilla ^a   Stiesch, Meike ^a   Haverich, Axel ^a   Kuehn, Christian ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Antimicrobial; CIED; Infection; Toxicity

Indexed keywords

BACITRACIN; BANEOCIN PRO INSTILLATIONE; CEFUROXIM; CEFUROXIME; DAPTOMYCIN; NEBACETIN; NEOMYCIN; OCTENISEPT; PIPERACILLIN; POVIDONE IODINE; TAZOBACTAM; UNCLASSIFIED DRUG; VANCOMYCIN; ANTIINFECTIVE AGENT; BIOMATERIAL; TOPICAL ANTIINFECTIVE AGENT;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIUM ADHERENCE; BACTERIUM CONTAMINATION; BIOCOMPATIBILITY; CARDIAC IMPLANTABLE ELECTROPHYSIOLOGICAL DEVICE; CARDIOVASCULAR THERAPEUTIC DEVICE; COLONY FORMING UNIT; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DEVICE INFECTION; ESCHERICHIA COLI; EVALUATION STUDY; FIBROBLAST; GROWTH; HUMAN; HUMAN CELL; IMMERSION; IMPLANTATION; IMPLANTED HEART PACEMAKER; IN VITRO STUDY; INCUBATION TIME; MICROVASCULAR ENDOTHELIAL CELL; MYOBLAST; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SCANNING ELECTRON MICROSCOPY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; THROMBOCYTE; ULTRASOUND; WOUND HEALING; ARTIFICIAL HEART PACEMAKER; CELL CULTURE; CELL SURVIVAL; COMPARATIVE STUDY; DRUG EFFECTS; ENDOTHELIUM CELL; EQUIPMENT DESIGN; GROWTH, DEVELOPMENT AND AGING; MEDICAL DEVICE CONTAMINATION; MICROBIOLOGY; PREVENTION AND CONTROL; TIME; TOXICITY;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, LOCAL; BACITRACIN; BACTERIAL ADHESION; CELL SURVIVAL; CELLS, CULTURED; COATED MATERIALS, BIOCOMPATIBLE; ENDOTHELIAL CELLS; EQUIPMENT CONTAMINATION; EQUIPMENT DESIGN; ESCHERICHIA COLI; FIBROBLASTS; HUMANS; MYOBLASTS, SKELETAL; NEOMYCIN; PACEMAKER, ARTIFICIAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; TIME FACTORS;

EID: 84896996944     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eut222     Document Type: Article

References (39)

1. Hayes DL, Furman S. Cardiac pacing: Gow it started, where we are, where we are going. Pacing Clin Electrophysiol 2004;27:693-704
2. PatwalaAY, Wright DJ. Device based treatment of heart failure. Postgrad Med J 2005; 81:286-91
3. Voigt A, Shalaby A, Saba S. Continued rise in rates of cardiovascular implantable electronic device infections in the United States: Temporal trends and causative insights. Pacing Clin Electrophysiol 2010;33:414-9
4. Zhan C, Baine WB, Sedrakyan A, Steiner C. Cardiac device implantation in the United States from 1997 through 2004: A population-based analysis. J Gen Intern Med 2007;23:13-9
5. Uslan DZ, Tleyjeh IM, Baddour LM, Friedman PA, Jenkins SM, St Sauver JL, et al. Temporal trends in permanent pacemaker implantation: A population-based study. Am Heart J 2008;155:896-903
6. Lin G, Meverden RA, Hodge DO, Uslan DZ, Hayes DL, Brady PA. Age and gender trends in implantable cardioverter defibrillator utilization: A population based study. J Interv Card Electrophysiol 2008;22:65-70
7. Cabell CH, Heidenreich PA, Chu VA, Moore CM, Stryjewski ME, Corey GR, et al. Increasing rates of cardiac device infections among medicare beneficiaries. Am Heart J 2004;147:582-6
8. Klug D, Balde M, Pavin D, Hidden-Lucet F, Clementy J, Sadoul N, et al. Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: Results of a large prospective study. Circulation 2007;116:1349-55
9. Chu VH, Crosslin DR, Friedman JY, Reed SD, Cabell CH, Griffiths RI, et al. Staphylococcus aureus bacteriemia in patients with prosthetic devices; costs and outcomes. Am J Med 2005;118:1416
10. Kuehn C, Graf K, HeuerW, Hilfiker A, Chaberny IF, StieschMet al. Economic implications of infections of implantable cardiac devices in a single institution. Eur J Cardiothorac Surg 2010;37:875-9
11. Pichlmaier M, Marwitz V, Kuehn C, Niehaus M, Klein G, BaraCet al. High prevalence of asymptomatic bacterial colonization of rhythm management devices. Europace 2008;10:1067-72
12. Borer A, Gilad J, Hyam E, Schlaeffer F, Schlaeffer P, Eskira S, et al. Prevention of infections associated with permanent cardiac antiarrhythmic devices by implementation of a comprehensive infection control program. Infect Control Hosp Epidemiol 2004;25: 492-7
13. Bongiorni MG, Marinskis G, Lip GY, Svendsen JH, Dobreanu D, Blomström-Lundqvist C. How European centres diagnose, treat, and prevent CIED infections: Results of an European Heart Rhythm Association survey. Europace 2012;14: 1666-9
14. Sohail MR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, WilsonWRet al. Management and outcome of permanent pacemaker and implantable cardioverterdefibrillator infections. J Am Coll Cardiol 2007;49:1851-9
15. Margey R, McCann H, Blake G, Keelan E, Galvin J, LynchMet al. Contemporary management of and outcomes from cardiac device related infections. Europace 2010;12: 64-70
16. Pichlmaier AM, Knigina L, Kutschka I, Bara C, Oswald H, Klein G, et al. Complete removal as a routine treatment for any cardiovascular implantable electronic device-Associated infection. J Thorac Cardiovasc Surg 2011;142:1482-90
17. Mela T, McGovern BA, Garan H, Vlahakes GJ, Torchiana DF, Ruskin J, et al. Long-Term infection rates associated with pectoral versus abdominal approach to cardioverterdefibrillator implants. Am J Cardiol 2001;88:750-3
18. Del Rio A, Anguera I, Miro JM, Mont L, Fowler VG Jr, Azqueta M, et al. Surgical treatment of pacemaker and defibrillator lead endocarditis: The impact of electrode lead extraction on outcome. Chest 2003;124:1451-9
19. Rohacek M,Weisser M, Kobza R, Schoenenberger AW, Pfyffer GE, Frei R, et al. Bacterial colonization and infection of electrophysiological cardiac devices detected with sonication and swab culture. Circulation 2010;121:1691-7
20. Tarakji KG, Chan EJ, Cantillon DJ, Doonan AL, Hu T, Schmitt S, et al. Cardiac implantable electronic device infections: Presentation, management, and patientoutcomes. Heart Rhythm 2010;7:1043-7
21. Anselmino M, Vinci M, Comoglio C, Rinaldi M, Bongiorni TG, Trevi GP, et al. Bacteriology of infected extracted pacemaker and ICD leads. J Cardiovasc Med (Hagerstown) 2009;10:693-8
22. Bongiorni MG, Tascini C, Tagliaferri E, Di Cori A, Soldati E, Leonildi A, et al. Microbiology of cardiac implantable electronic device infections. Europace 2012;14: 1334-9
23. Hoiby N, Ciofu O, Johansen HK, Song ZJ, Moser C, Jensen PØ, et al. The clinical impact of bacterial biofilms. Int J Oral Sci 2011;3:55-65
24. Thomson CH. Biofilms: Do they affect wound healing? Int Wound J 2011;8:63-7
25. Schierle CF,De la Garza M, Mustoe TA, Galiano RD. Staphylococcal biofilms impair wound healing by delaying reepithelialization in a murine cutaneous wound model. Wound Repair Regen 2009;27:354-9
26. Da Costa A, Kirkorian G, CucheratM, Delahaye F, Chevalier P, CerisierA, et al. Antibiotic prophylaxis for permanent pacemaker implantation: A meta-Analysis. Circulation 1998;97:1796-801
27. Lakkireddy D, Valsareddi S, Ryschon K, Basarkodu K, Rovang K, Mohiuddin SM, et al. The impact of povidone-iodine pocket irrigation use on pacemaker and defibrillator infections. Pacing Clin Electrophysiol 2005;28:789-94
28. Hübner NO, Siebert J, Kramer A. Octenidine dihydrochloride, a modern antiseptic for skin, mucous membranes and wounds. Skin Pharmacol Physiol 2010; 23:244-58
29. Parsonnet V, Roelke M. The cephalic vein cutdown versus subclavian puncture for pacemaker/ICD lead implantation. Pacing Clin Electrophysiol 1999;22: 695-7
30. Straub M, Lodemann P, Holroyd P, Jahn R, Hell SW. Live cell imaging by multifocal mulitphoton microscopy. Eur J Cell Biol 2000;79:726-34
31. Berridge MV, Herst PM, Tan AS. Tetrazolium dyes as tools in cell biology: New insights into their cellular reduction. Biotechnol Annu Rev 2005;11:127-52
32. Enzler MJ, Berbari E, Osmon DR. Antimicrobial prophylaxis in adults. Mayo Clin Proc 2011;86:686-701
33. Bertaglia E, Zerbo F, Zardo S, Barzan D, Zoppo F, Pascotto P. Antibiotic prophylaxis with a single dose of cefazolin during pacemaker implantation: Incidence of long-Term infective complications. Pacing Clin Electrophysiol 2006;29: 29-33
34. Freiler JF, Steel KE, Hagan LL, Rathkopf MM, Roman-Gonzalez J. Intraoperative anaphylaxis to bacitracin during pacemaker change and laser lead extraction. Ann Allergy Asthma Immunol 2005;95:389-95
35. Knigina L, Kühn C, Kutschka I, Oswald H, Klein G, Haverich A, et al. Treatment of patients with recurrent or persistent infection of cardiac implantable electronic devices. Europace 2010;12:1275-81
36. Qadan M, Cheadle WG. Common microbial pathogens in surgical practice. Surg Clin North Am 2009;144:359-66
37. Bjerkan G, Witsø E, Bergh K. Sonification is superior to scraping for retrieval of bacteria in biofilm on titanium and steel surfaces in vitro. Acta Orthop 2009;80:245-50
38. Darby IA, Hewitson TD. Fibroblast differentiation in wound healing and fibrosis. Int Rev Cytol 2007;257:143-79
39. Dire DJ, Coppola M, DwyerDA, Lorrette JJ, Karr JL. Prospective evaluation of topical antibiotics for preventing infections in uncomplicated soft-Tissuewounds repaired in the ED. Acad Emerg Med 1995;2:4-10.